Skip to content

Clinical trials

Phase 2 Carcinoma, Medullary trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Medullary Phase: Phase 2 Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20032
20043
20053
20064
20072
20082
20102
20122
20131
20142
20172
20181
20192
20201
20212
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Terminated5
Active, not recruiting3
Withdrawn3
Not yet recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)8
M.D. Anderson Cancer Center2
Amgen1
Antonio Fojo1
Assistance Publique - Hôpitaux de Paris1
Bayer1
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.1
Columbia University1
Delcath Systems Inc.1
Eanm Research Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Medullary36
Thyroid Neoplasms21
Thyroid Cancer, Papillary13
Adenocarcinoma, Follicular12
Thyroid Carcinoma, Anaplastic9
Head and Neck Neoplasms8
Pheochromocytoma5
Carcinoma, Hepatocellular4
Pancreatic Neoplasms3
Somatostatinoma3

Trials

Showing 76 to 36 of 36. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.